How to Become Smarter (81 page)

425.   Doubt TJ, Mayers DL, Flynn ET:
Transient cardiac sinus dysrhythmia occurring after cold water immersion.
Am J Cardiol
1987,
59
(15):1421-1422.

426.   Houdas Y, Deklunder G, Lecroart JL:
Cold exposure and ischemic heart disease.
Int J Sports Med
1992,
13
(Suppl 1):S179-S181.

427.   Lader EW, Kronzon I:
Ice-water-induced arrhythmias in a patient with ischemic heart disease.
Ann Intern Med
1982,
96
(5):614-615.

428.   Arican N, Kaya M, Kalayci R, Kucuk M, Cimen V, Elmas I:
Effects of acute cold exposure on blood-brain barrier permeability in acute and chronic hyperglycemic rats.
Forensic Sci Int
2002,
125
(2-3):137-141.

429.   Ben-Nathan D, Lustig S, Danenberg HD:
Stress-induced neuroinvasiveness of a neurovirulent noninvasive Sindbis virus in cold or isolation subjected mice.
Life Sci
1991,
48
(15):1493-1500.

430.   Ben-Nathan D, Lustig S, Feuerstein G:
The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus.
Arch Virol
1989,
109
(1-2):1-10.

431.   Ben-Nathan D, Lustig S, Kobiler D, Danenberg HD, Lupu E, Feuerstein G:
Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress.
J Med Virol
1992,
38
(3):159-166.

432.   Wan R, Camandola S, Mattson MP:
Dietary supplementation with 2-deoxy-D-glucose improves cardiovascular and neuroendocrine stress adaptation in rats.
Am J Physiol Heart Circ Physiol
2004,
287
(3):H1186-H1193.

433.   Elmas I, Kucuk M, Kalayci RB, Cevik A, Kaya M:
Effects of profound hypothermia on the blood-brain barrier permeability in acute and chronically ethanol treated rats.
Forensic Sci Int
2001,
119
(2):212-216.

434.   Bar-On R:
The Bar-On model of emotional-social intelligence (ESI).
Psicothema
2006,
18
(Suppl):13-25.

435.   Nowicki SJ, Duke MP:
Individual differences in the nonverbal communication of affect: the Diagnostic Analysis of Nonverbal Accuracy Scale.
J Nonverbal Behav
1994,
19
:9-35.

436.   Matsumoto D, LeRoux JA, Wilson-Cohn C, Raroque J, Kooken K:
A new test to measure emotion recognition ability: Matsumoto and Ekman’s Japanese and Caucasian Brief Affect Recognition Test (JACBART).
J Nonverbal Behav
2000,
24
:179-209.

437.   Lane RD, Quinlan DM, Schwartz GE, Walker PA, Zeitlin SB:
The Levels of Emotional Awareness Scale: a cognitive-developmental measure of emotion.
J Pers Assess
1990,
55
(1-2):124-134.

438.   Trentacosta CJ, Izard CE:
Kindergarten children’s emotion competence as a predictor of their academic competence in first grade.
Emotion
2007,
7
(1):77-88.

439.   Tett RP, Fox KE, Wang A:
Development and validation of a self-report measure of emotional intelligence as a multidimensional trait domain.
Pers Soc Psychol Bull
2005,
31
(7):859-888.

440.   Zeidner M, Matthews G, Roberts RD:
Emotional intelligence in the workplace: a critical review.
Applied Psychology
2004,
53
(3):371-399.

441.   Ciarrochi JV, Chan AYC, Caputi P:
A critical evaluation of the emotional intelligence construct.
Personal Individ Differ
2000,
28
(3):539-561.

442.   Humphrey N, Curran A, Morris E, Farrell P, Woods K:
Emotional intelligence and education: a critical review.
Educational Psychology
2007,
27
(2):235-254.

443.   Schutte NS, Malouff JM, Hall LE, Haggerty DJ, Cooper JT:
Development and validation of a measure of emotional intelligence.
Personal Individ Differ
1998,
25
:167-177.

444.   Brackett MA, Rivers SE, Shiffman S, Lerner N, Salovey P:
Relating emotional abilities to social functioning: a comparison of self-report and performance measures of emotional intelligence.
J Pers Soc Psychol
2006,
91
(4):780-795.

445.   Salovey P, Grewal D:
The science of emotional intelligence.
Current Directions in Psychological Science
2005,
14
(6):281-285.

446.   Farzin D, Mansouri N:
Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test.
Eur Neuropsychopharmacol
2006,
16
(5):324-328.

447.   Aricioglu F, Altunbas H:
Harmane induces anxiolysis and antidepressant-like effects in rats.
Ann N Y Acad Sci
2003,
1009
:196-201.

448.   Iversen L, Iversen S, Bloom FE:
Introduction to Neuropsychopharmacology
.
USA: Oxford University Press; 2008.

449.   Kulkarni SK, Singh K, Bishnoi M:
Comparative behavioural profile of newer antianxiety drugs on different mazes.
Indian J Exp Biol
2008,
46
(9):633-638.

450.   Tyrer P, Baldwin D:
Generalised anxiety disorder.
Lancet
2006,
368
(9553):2156-2166.

451.   Freitas A, da Paz JA, Casella EB, Marques-Dias MJ:
Ketogenic diet for the treatment of refractory epilepsy: a 10 year experience in children.
Arq Neuropsiquiatr
2007,
65
(2B):381-384.

452.   Schildkraut JJ:
The catecholamine hypothesis of affective disorders: a review of supporting evidence.
Am J Psychiatry
1965,
122
(5):509-522.

453.   Schildkraut JJ:
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965.
J Neuropsychiatry Clin Neurosci
1995,
7
(4):524-533; discussion 523-524.

454.   Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R:
Selective publication of antidepressant trials and its influence on apparent efficacy.
N Engl J Med
2008,
358
(3):252-260.

455.   Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT:
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.
PLoS Med
2008,
5
(2):e45.

456.   Olie JP, Bayle F, Kasper S:
A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression.
Encephale
2003,
29
(4 Pt 1):322-328.

457.   Lacasse JR, Leo J:
Serotonin and depression: a disconnect between the advertisements and the scientific literature.
PLoS Med
2005,
2
(12):e392.

458.   Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D:
Dopamine and drug addiction: the
nucleus accumbens
shell connection.
Neuropharmacology
2004,
47
(Suppl 1):227-241.

459.   Ikemoto S:
Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies.
J Neurosci
2003,
23
(28):9305-9311.

460.   Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S:
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.
Am J Psychiatry
2007,
164
(4):630-637.

461.   Saeedi H, Remington G, Christensen BK:
Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood.
Schizophr Res
2006,
85
(1-3):222-231.

462.   Leterme L, Singlan YS, Auclair V, Le Boisselier R, Frimas V:
Misuse of tianeptine: five cases of abuse.
Ann Med Interne (Paris)
2003,
154
(Spec No 2):S58-S63.

463.   Landen M, Thase ME:
A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT
₂
receptors.
Psychopharmacol Bull
2006,
39
(1):147-166.

464.   Zarate CA, Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK:
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Arch Gen Psychiatry
2006,
63
(8):856-864.

465.   Furey ML, Drevets WC:
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Arch Gen Psychiatry
2006,
63
(10):1121-1129.

466.   Lieberman HR, Yeghiayan SK, Maher TJ:
A low-protein diet alters rat behavior and neurotransmission in normothermic and hyperthermic environments.
Brain Res Bull
2005,
66
(2):149-154.

467.   Berk M, Dodd S, Kauer-Sant’anna M, Malhi GS, Bourin M, Kapczinski F, Norman T:
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder.
Acta Psychiatr Scand Suppl
2007(434):41-49.

468.   Pitchot W, Scantamburlo G, Ansseau M:
Dopamine and depression: the forgotten neurotransmitter.
Rev Med Liege
2008,
63
(5-6):378-384.

469.   Stein DJ:
Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry.
CNS Spectr
2008,
13
(7):561-565.

470.   Stein MB, Stein DJ:
Social anxiety disorder.
Lancet
2008,
371
(9618):1115-1125.

471.   Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B:
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram.
J Clin Psychiatry
2006,
67
(11):1741-1746.

472.   Beley A, Beley P, Rochette L, Bralet J:
Effect of cold exposure on synthesis of cerebral dopamine.
J Physiol (Paris)
1976,
72
(8):1029-1034.

473.   Zhang H, Wisniewski SR, Bauer MS, Sachs GS, Thase ME:
Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants.
Compr Psychiatry
2006,
47
(3):161-168.

474.   Lewandowska A, Rybakowski J:
Neuropsychological aspects of the manic syndrome in the course of bipolar affective illness.
Psychiatr Pol
2009,
43
(3):275-286.

475.   Janka Z:
Artistic creativity and bipolar mood disorder.
Orv Hetil
2004,
145
(33):1709-1718.

476.   Oishi S, Diener E, Lucas RE:
The optimum level of well-being: can people be too happy?
Perspectives on Psychological Science
2007,
2
(4):346-360.

477.   Fredrickson BL:
The role of positive emotions in positive psychology: The broaden-and-build theory of positive emotions.
American Psychologist
2001,
56
:218-226.

478.   Melton RJ:
The role of positive affect in syllogism performance.
Personality and Social Psychology Bulletin
1995,
21
:788-794.

479.   Zarinpoush F, Cooper M, Moylan S:
The effects of happiness and sadness on moral reasoning.
Journal of Moral Education
2000,
29
:397-412.

480.   Bodenhausen GV, Kramer GP, Seusser K:
Happiness and stereotypic thinking in social judgment.
Journal of Personality and Social Psychology
1994,
66
:621-632.

481.   Sinclair RC, Mark MM:
The effects of mood state on judgmental accuracy: Processing strategy as a mechanism.
Cognition and Emotion
1995,
9
:417-438.